COVID‑19 Alert: Stay home if you feel unwell. If you have a fever, cough and difficulty breathing, seek medical attention. Follow the directions of your local health authority. Source WHO

We have a lockdown, "Working from HOME" Please reach out for any queries at: help@alliedmarketresearch.com & Int'l : +1-503-894-6022, (UK) : +44-845-528-1300

Global Biobanking Market Expected to Reach $68,084 Million, Globally, by 2025


quote Increase in incidence of chronic disease such as cancer bolsters the market of biobanking. Since the use of conventional therapies have serious side-effects, integrating it with stem cell therapy reduces the damage and hence the increased demand.” quote

Pallavi Jaiswal
Senior Analyst, Healthcare Research at AMR

Get 20% Free Customization In This Report
Follow us on Social Media:       

According to a new report published by Allied Market Research, titled, "Biobanking Market by Specimen Type, Type of Biobank, Ownership, and Application: Global Opportunity Analysis and Industry Forecast, 20182025," the global biobanking market was valued at $47,062 million in 2017, and is estimated to reach $68,084 million by 2025, growing at a CAGR of 4.6% from 2017 to 2025.

Biobanking refers to the process in which biological samples are collected and stored for research and clinical care. The major factors that contribute towards the market growth include rise in funding by private & government organizations for biobanking and increase in application areas of biobanked samples. Biobanked specimens are used in the treatment of several chronic diseases, and thus increase in incidence of disease such as cancer further supports the market growth. However, ethical issues related to biobanking and lack of awareness about it are expected to impede the market growth. Conversely, unmet medical needs in the emerging nations are expected to provide lucrative opportunity for the market.

The blood product segment generated the maximum revenue in 2017, accounting for more than two-fifths share of the global biobanking market in 2017. On the other hand, solid tissue segment is expected to witness the highest CAGR during the forecast period.

By type of biobank, the disease-based biobank segment generated the maximum revenue in 2017 and population-based biobank segment is expected to grow at a CAGR of 5.2% during the forecast period.

Key Findings of the Biobanking Market:

  • The research segment contributed for nearly two-thirds share of the global biobanking market in 2017.
  • The private organization segment is projected to grow at a significant CAGR from 2018 to 2025.
  • In 2017, national/regional agencies led the overall biobanking market, and is projected to grow at a CAGR of 4.2% during the forecast period.
  • Germany and France are the major shareholders, which collectively accounted for more than one-third share of the Europe biobanking market in 2017.
  • Japan is the major shareholder, accounting for more than one-third share of the Asia-Pacific biobanking market in 2017.

Europe market is projected to dominate the global biobanking market in terms of revenue during the forecast period. This is majorly due to the increase in number of biobanks in the region coupled with increasing research activities related to biobanking. On the other hand, the Asia-Pacific market is expected to grow at the highest CAGR of 5.7% during the forecast period.

The major companies profiled in the report are ASKION GmbH, CTI BIOTECH, Cureline, Inc., Excilone SARL, Firalis S.A., Hamilton Company, LabVantage Solutions, Inc., LGC Limited, PrecisionMed, Inc., and ProMedDx LLC.

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com


For Media Inquiries, Please Contact

Ram D
Communications Officer
Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at


First time buyer?
Check offers and discount on this report
To get this report

Click Here

quote Biobanking Market by Specimen Type (Blood products, Solid tissue, and Cell lines), Type of Biobank (Population Based Biobanks, and Disease-Oriented Biobanks), Ownership (National/Regional agencies, Non-profit organization, University, and Private), and Application (Therapeutic, and Research) - Global Opportunity Analysis and Industry Forecast, 2018-2025 quote

View Report

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time of readers


Featured Readings


Get Fresh content delivered

Get insights on topics that matter to your business. Stay updated on the area that interests you.

Get Industry Data Alerts

Buy Full Version
"Global Biobanking Market"
Purchase Enquiry